COPD Technology Launch: Samay's Strategy for Latin America

Thursday, 9 October 2025, 12:02

COPD technology plans are taking center stage as Samay aims to launch solutions in Latin America prior to entering the US market. Dr. Maria Artunduaga, founder and CEO of Samay, shares insights on the rapid evolution of her startup following its success at the MedTech Innovator competition. This strategic move highlights the pressing need for innovative treatments in the field of chronic obstructive pulmonary disease.

COPD Technology Launch: Samay's Strategy for Latin America

COPD Technology Considerations

In recent developments, Samay has decided to introduce its innovative COPD technology in Latin America ahead of the US release. This initiative signifies a crucial step in addressing healthcare needs in regions that are often overlooked.

Strategic Insights

According to Dr. Maria Artunduaga, CEO of Samay, the journey has transformed significantly after clinching victory in the MedTech Innovator competition. This achievement has opened multiple avenues for expansion and opportunities for collaboration in the healthcare sector.

Focus on patient accessibility and treatment efficacy.
Pioneering strategies for deployment in healthcare markets.
Leveraging award recognition for broader outreach.

Looking Ahead

The urgency for effective solutions in managing COPD underscores the importance of Samay's trajectory in the medical technology landscape.

This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.